At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at https://www.jnj.com/. POSITION SUMMARY: The late development Compound Development Team Leader (CDTL) is responsible for development and execution of the compound strategy for a selected molecular entity, and operational implementation, delivered through the effective leadership of a cross-functional Compound Development Team (CDT). The CDTL is accountable for Phase 2b/3/3b/4 and post marketing clinical trials related to the compound development program and other required cross-functional activities related to lifecycle management. The CDTL leads the team to develop products in a timely and cost effective manner and is accountable for the execution of the compound strategy. Team leadership via matrix interactions includes individuals from TA strategy, GCSO, global regulatory affairs, project management, finance, legal, quality assurance, quality monitoring & compliance, clinical supplies unit, drug discovery, early clinical development, strategic marketing, CM&C, preclinical department and other scientific and business related disciplines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees